Andal, Salbi S.
HRN: 28-80-84 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/10/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/10/2026
04/17/2026
IV
500mg
Q 8
Amoebiasis
Checking Initial Appropriateness